Search
Descriptor English: Ceftazidime
Descriptor Spanish: Ceftazidima
Descriptor ceftazidima
Scope note: Antibacteriano semisintético de amplio espectro derivado de la CEFALORIDINA que se utiliza especialmente en las infecciones por Pseudomonas y otras infecciones por gramnegativos en pacientes debilitados.
Descriptor Portuguese: Ceftazidima
Descriptor French: Ceftazidime
Entry term(s): Ceftazidime Anhydrous
Ceftazidime Pentahydrate
Fortaz
Fortum
GR 20263
GR-20263
GR20263
LY 139381
LY-139381
LY139381
Pyridinium, 1-((7-(((2-amino-4-thiazolyl)((1-carboxy-1-methylethoxy)imino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-, inner salt, pentahydrate, (6R-(6alpha,7beta(Z)))-
Tazidime
Tree number(s): D02.065.589.099.249.210.150
D02.886.665.074.210.150
D03.633.100.300.249.210.150
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D002442
Scope note: Semisynthetic, broad-spectrum antibacterial derived from CEPHALORIDINE and used especially for Pseudomonas and other gram-negative infections in debilitated patients.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Anti-Bacterial Agents
Registry Number: 9M416Z9QNR
Previous Indexing: Cephalosporins (1966-1984)
History Note: 1985
DeCS ID: 2478
Unique ID: D002442
NLM Classification: QV 350.5.C3
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1985/01/01
Date of Entry: 1984/05/24
Revision Date: 2018/05/21
Ceftazidime - Preferred
Concept UI M0003729
Scope note Semisynthetic, broad-spectrum antibacterial derived from CEPHALORIDINE and used especially for Pseudomonas and other gram-negative infections in debilitated patients.
Preferred term Ceftazidime
Fortaz - Narrower
Concept UI M0351087
Preferred term Fortaz
Fortum - Narrower
Concept UI M0003730
Preferred term Fortum
Ceftazidime Pentahydrate - Narrower
Concept UI M000638405
Preferred term Ceftazidime Pentahydrate
LY-139381 - Narrower
Concept UI M0351085
Preferred term LY-139381
Entry term(s) LY 139381
LY139381
Tazidime - Narrower
Concept UI M0351084
Preferred term Tazidime
Ceftazidime Anhydrous - Narrower
Concept UI M0585640
Preferred term Ceftazidime Anhydrous
Pyridinium, 1-((7-(((2-amino-4-thiazolyl)((1-carboxy-1-methylethoxy)imino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-, inner salt, pentahydrate, (6R-(6alpha,7beta(Z)))- - Narrower
Concept UI M000642257
Preferred term Pyridinium, 1-((7-(((2-amino-4-thiazolyl)((1-carboxy-1-methylethoxy)imino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-, inner salt, pentahydrate, (6R-(6alpha,7beta(Z)))-
GR-20263 - Narrower
Concept UI M0351086
Preferred term GR-20263
Entry term(s) GR 20263
GR20263



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey